Direct vasoconstrictor effect of prostaglandin E2 on renal interlobular arteries:: role of the EP3 receptor

被引:30
|
作者
van Rodijnen, William F.
Korstjens, Iolente J.
Legerstee, Natalee
ter Wee, Piet M.
Tangelder, Geert-Jan
机构
[1] Free Univ Amsterdam, Cardiovasc Res Inst, Physiol Lab, Med Ctr, NL-1081 BT Amsterdam, Netherlands
[2] Free Univ Amsterdam, Dept Nephrol, Cardiovasc Res Inst, Med Ctr, NL-1081 BT Amsterdam, Netherlands
关键词
interlobular arteries; vasoconstriction;
D O I
10.1152/ajprenal.00351.2005
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Evidence indicates that prostaglandin E-2 ( PGE(2)) preferentially affects preglomerular renal vessels. However, whether this is limited to small-caliber arterioles or whether larger vessels farther upstream also respond to PGE(2) is currently unclear. In the present study, we first investigated the effects of PGE(2) along the preglomerular vascular tree and subsequently focused on proximal interlobular arteries ( ILAs). Proximal ILAs in hydronephrotic rat kidneys as well as isolated vessels from normal kidneys constricted in response to PGE(2), both under basal conditions and after the induction of vascular tone. By contrast, smaller vessels, i. e., distal ILAs and afferent arterioles, exhibited PGE(2)-induced vasodilation. Endothelium removal and pretreatment of single, isolated proximal ILAs with an EP1 receptor blocker ( SC51322, 1 mu mol/ l) or a thromboxane A(2) receptor blocker ( SQ29548, 1 mu mol/ l) did not prevent vasoconstriction to PGE(2). Furthermore, in the presence of SC51322, responses of these vessels to PGE(2) and the EP1/EP3 agonist sulprostone were superimposable, indicating that PGE(2)-induced vasoconstriction is mediated by EP3 receptors on smooth muscle cells. Immunohistochemical staining of proximal ILAs confirmed the presence of EP3 receptor protein on these cells and the endothelium. Adding PGE(2) to normal isolated kidneys induced a biphasic flow response, i. e., an initial flow increase at PGE(2) concentrations <= 0.1 mu mol/ l followed by a flow decrease at 1 mu mol/ l PGE(2). Thus our results demonstrate that PGE(2) affects multiple segments of the preglomerular vascular tree in a different way. At the level of the proximal ILAs, PGE(2) had a direct vasoconstrictor action mediated by EP3 receptors.
引用
收藏
页码:F1094 / F1101
页数:8
相关论文
共 50 条
  • [1] Prostaglandin E2 induced contraction of human intercostal arteries is mediated by the EP3 receptor
    Longrois, Dan
    Gomez, Ingrid
    Foudi, Nabil
    Topal, Gokce
    Dhaouadi, Malek
    Kotelevets, Larissa
    Chastre, Eric
    Norel, Xavier
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2012, 681 (1-3) : 55 - 59
  • [2] The deleterious role of the prostaglandin E2 EP3 receptor in angiotensin II hypertension
    Bryson, Timothy D.
    Pandrangi, Teja S.
    Khan, Safa Z.
    Xu, Jiang
    Pavlov, Tengis S.
    Ortiz, Pablo A.
    Peterson, Edward
    Harding, Pamela
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2020, 318 (04): : H867 - H882
  • [3] Contractile role of prostaglandin E2 receptor subtype EP3 on liver myofibroblasts
    Ayabe, Shinya
    Maruyama, Tomoharu
    Murata, Takahisa
    Hori, Masatoshi
    Ozaki, Hiroshi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 58P - 58P
  • [4] Modulation of platelet aggregation by the EP3 receptor for prostaglandin E2
    Athirakul, K
    Thomas, DW
    Fabre, JE
    Koller, B
    Coffman, TM
    HYPERTENSION, 2000, 36 (04) : 721 - 721
  • [5] The EP3 receptor for prostaglandin E2 in peripheral arterial disease
    Bjarnadottir, Maria
    Andresson, Thorkell
    Gudmundsson, Kolbeinn
    Gurney, Mark
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (06) : E109 - E109
  • [6] The role of Cox-2 and prostaglandin E2 receptor EP3 in pancreatic β-cell death
    Amior, Livnat
    Srivastava, Rohit
    Nano, Rita
    Bertuzzi, Federico
    Melloul, Danielle
    FASEB JOURNAL, 2019, 33 (04): : 4975 - 4986
  • [7] Prostaglandin E2 EP3 receptor modulation of insulin secretion in diabetes
    Ceddia, Ryan P.
    Gannon, Maureen
    Breyer, Richard M.
    FASEB JOURNAL, 2013, 27
  • [8] Harnessing the antiplatelet effects of prostaglandin E2 by EP3 receptor blockade
    Iyu, D.
    Heptinstall, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 350 - 351
  • [9] Prostaglandin E2 Mediates Cough Via the EP3 Receptor.
    Maher, S. A.
    Birrell, M. A.
    Belvisi, M. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [10] Prostaglandin E2 Reduces Cardiac Contractility via EP3 Receptor
    Gu, Xiaosong
    Xu, Jiang
    Zhu, Liping
    Bryson, Timothy
    Yang, Xiao-Ping
    Peterson, Edward
    Harding, Pamela
    CIRCULATION-HEART FAILURE, 2016, 9 (08)